Team members involved:

CARE Fertility is the UK's leading independent provider of fertility treatments, genetic diagnosis and embryo screening techniques. It operates seven full-service clinics across the UK and Ireland, supported by a network of 19 satellite centres.  The company has been at the forefront of IVF science for 20 years, and its clinicians are able to offer the most advanced and effective procedures available today.

  • Investment: June 2012
  • Sector: Healthcare
  • Business: Fertility services
  • Growth Strategy: Roll-out and buy-and-build

Why we invested

CARE Fertility operates in a growing market, due to declining fertility rates and other lifestyle factors. The company is the clear market leader, and has built an outstanding reputation based on its superior success rates and clinical leadership. This was an opportunity to back a management team with an unrivalled track record in the sector, to expand its network through the roll-out and acquisition of new clinics.

The story so far

Since our investment, CARE Fertility has acquired clinics in London and Tunbridge Wells, and opened new clinics in Dublin and Birmingham. In addition, it has been at the forefront of new clinical technology, including developing the time lapse embryo imaging technique, CAREmaps, which has been found to greatly increase patient success rates.

Website: Read more about our Healthcare strategy

Bowmark get it. They really understand our business and our industry, and have helped us to realise our objectives. The experience has been a very positive one.

Simon Fishel, Chief Executive
Back to portfolio